nodes	percent_of_prediction	percent_of_DWPC	metapath
Levofloxacin—TOP2A—Epirubicin—testicular cancer	0.166	0.229	CbGbCtD
Levofloxacin—TOP2A—Etoposide—testicular cancer	0.129	0.178	CbGbCtD
Levofloxacin—TOP2A—Doxorubicin—testicular cancer	0.088	0.122	CbGbCtD
Levofloxacin—SLC22A2—Vinblastine—testicular cancer	0.072	0.0994	CbGbCtD
Levofloxacin—SLC22A2—Cisplatin—testicular cancer	0.066	0.0911	CbGbCtD
Levofloxacin—ABCB1—Dactinomycin—testicular cancer	0.0306	0.0422	CbGbCtD
Levofloxacin—SLC22A6—Methotrexate—testicular cancer	0.0256	0.0353	CbGbCtD
Levofloxacin—CYP3A4—Ifosfamide—testicular cancer	0.0216	0.0299	CbGbCtD
Levofloxacin—CYP1A2—Etoposide—testicular cancer	0.0197	0.0273	CbGbCtD
Levofloxacin—ABCB1—Vinblastine—testicular cancer	0.0192	0.0265	CbGbCtD
Levofloxacin—ABCB1—Cisplatin—testicular cancer	0.0176	0.0243	CbGbCtD
Levofloxacin—ABCB1—Etoposide—testicular cancer	0.0173	0.0238	CbGbCtD
Levofloxacin—ABCB1—Doxorubicin—testicular cancer	0.0118	0.0163	CbGbCtD
Levofloxacin—CYP3A4—Vinblastine—testicular cancer	0.0115	0.0158	CbGbCtD
Levofloxacin—ABCB1—Methotrexate—testicular cancer	0.0114	0.0157	CbGbCtD
Levofloxacin—CYP3A4—Etoposide—testicular cancer	0.0103	0.0143	CbGbCtD
Levofloxacin—CYP3A4—Doxorubicin—testicular cancer	0.00705	0.00974	CbGbCtD
Levofloxacin—TOP2A—Vindesine—Vinblastine—testicular cancer	0.00104	0.188	CbGdCrCtD
Levofloxacin—TOP2A—Vinorelbine—Vinblastine—testicular cancer	0.000655	0.118	CbGdCrCtD
Levofloxacin—TOP2A—Podofilox—Etoposide—testicular cancer	0.000654	0.118	CbGdCrCtD
Levofloxacin—TOP2A—Teniposide—Etoposide—testicular cancer	0.000654	0.118	CbGdCrCtD
Levofloxacin—TOP2A—Vincristine—Vinblastine—testicular cancer	0.00056	0.101	CbGdCrCtD
Levofloxacin—TOP2A—Idarubicin—Epirubicin—testicular cancer	0.000341	0.0617	CbGdCrCtD
Levofloxacin—TOP2A—Daunorubicin—Epirubicin—testicular cancer	0.000341	0.0617	CbGdCrCtD
Levofloxacin—TOP2A—Doxorubicin—Epirubicin—testicular cancer	0.000341	0.0617	CbGdCrCtD
Levofloxacin—TOP2A—Epirubicin—Doxorubicin—testicular cancer	0.000316	0.0571	CbGdCrCtD
Levofloxacin—TOP2A—Idarubicin—Doxorubicin—testicular cancer	0.000316	0.0571	CbGdCrCtD
Levofloxacin—TOP2A—Daunorubicin—Doxorubicin—testicular cancer	0.000316	0.0571	CbGdCrCtD
Levofloxacin—Pharyngitis—Epirubicin—testicular cancer	9.22e-05	0.000341	CcSEcCtD
Levofloxacin—Cardiac disorder—Methotrexate—testicular cancer	9.21e-05	0.000341	CcSEcCtD
Levofloxacin—Urinary tract disorder—Epirubicin—testicular cancer	9.17e-05	0.000339	CcSEcCtD
Levofloxacin—Oedema peripheral—Epirubicin—testicular cancer	9.15e-05	0.000339	CcSEcCtD
Levofloxacin—Haematuria—Doxorubicin—testicular cancer	9.13e-05	0.000338	CcSEcCtD
Levofloxacin—Connective tissue disorder—Epirubicin—testicular cancer	9.13e-05	0.000338	CcSEcCtD
Levofloxacin—Urethral disorder—Epirubicin—testicular cancer	9.1e-05	0.000337	CcSEcCtD
Levofloxacin—Hepatobiliary disease—Doxorubicin—testicular cancer	9.05e-05	0.000335	CcSEcCtD
Levofloxacin—Epistaxis—Doxorubicin—testicular cancer	9.03e-05	0.000334	CcSEcCtD
Levofloxacin—Angiopathy—Methotrexate—testicular cancer	9e-05	0.000333	CcSEcCtD
Levofloxacin—Sinusitis—Doxorubicin—testicular cancer	8.98e-05	0.000332	CcSEcCtD
Levofloxacin—Immune system disorder—Methotrexate—testicular cancer	8.96e-05	0.000332	CcSEcCtD
Levofloxacin—Visual impairment—Epirubicin—testicular cancer	8.95e-05	0.000331	CcSEcCtD
Levofloxacin—Mediastinal disorder—Methotrexate—testicular cancer	8.94e-05	0.000331	CcSEcCtD
Levofloxacin—Agranulocytosis—Doxorubicin—testicular cancer	8.93e-05	0.000331	CcSEcCtD
Levofloxacin—Chills—Methotrexate—testicular cancer	8.9e-05	0.00033	CcSEcCtD
Levofloxacin—Nausea—Ifosfamide—testicular cancer	8.85e-05	0.000328	CcSEcCtD
Levofloxacin—Diarrhoea—Cisplatin—testicular cancer	8.79e-05	0.000325	CcSEcCtD
Levofloxacin—Erythema multiforme—Epirubicin—testicular cancer	8.78e-05	0.000325	CcSEcCtD
Levofloxacin—Alopecia—Methotrexate—testicular cancer	8.77e-05	0.000325	CcSEcCtD
Levofloxacin—Bradycardia—Doxorubicin—testicular cancer	8.75e-05	0.000324	CcSEcCtD
Levofloxacin—Mental disorder—Methotrexate—testicular cancer	8.69e-05	0.000322	CcSEcCtD
Levofloxacin—Eye disorder—Epirubicin—testicular cancer	8.68e-05	0.000321	CcSEcCtD
Levofloxacin—Hypersensitivity—Etoposide—testicular cancer	8.67e-05	0.000321	CcSEcCtD
Levofloxacin—Tinnitus—Epirubicin—testicular cancer	8.66e-05	0.00032	CcSEcCtD
Levofloxacin—Malnutrition—Methotrexate—testicular cancer	8.64e-05	0.00032	CcSEcCtD
Levofloxacin—Erythema—Methotrexate—testicular cancer	8.64e-05	0.00032	CcSEcCtD
Levofloxacin—Haemoglobin—Doxorubicin—testicular cancer	8.64e-05	0.00032	CcSEcCtD
Levofloxacin—Cardiac disorder—Epirubicin—testicular cancer	8.62e-05	0.000319	CcSEcCtD
Levofloxacin—Flushing—Epirubicin—testicular cancer	8.62e-05	0.000319	CcSEcCtD
Levofloxacin—Rhinitis—Doxorubicin—testicular cancer	8.61e-05	0.000319	CcSEcCtD
Levofloxacin—Haemorrhage—Doxorubicin—testicular cancer	8.59e-05	0.000318	CcSEcCtD
Levofloxacin—Hepatitis—Doxorubicin—testicular cancer	8.59e-05	0.000318	CcSEcCtD
Levofloxacin—Hypoaesthesia—Doxorubicin—testicular cancer	8.55e-05	0.000316	CcSEcCtD
Levofloxacin—Pharyngitis—Doxorubicin—testicular cancer	8.53e-05	0.000316	CcSEcCtD
Levofloxacin—Urinary tract disorder—Doxorubicin—testicular cancer	8.49e-05	0.000314	CcSEcCtD
Levofloxacin—Oedema peripheral—Doxorubicin—testicular cancer	8.46e-05	0.000313	CcSEcCtD
Levofloxacin—Dysgeusia—Methotrexate—testicular cancer	8.46e-05	0.000313	CcSEcCtD
Levofloxacin—Asthenia—Etoposide—testicular cancer	8.44e-05	0.000313	CcSEcCtD
Levofloxacin—Connective tissue disorder—Doxorubicin—testicular cancer	8.44e-05	0.000313	CcSEcCtD
Levofloxacin—Angiopathy—Epirubicin—testicular cancer	8.43e-05	0.000312	CcSEcCtD
Levofloxacin—Urethral disorder—Doxorubicin—testicular cancer	8.42e-05	0.000312	CcSEcCtD
Levofloxacin—Immune system disorder—Epirubicin—testicular cancer	8.39e-05	0.00031	CcSEcCtD
Levofloxacin—Mediastinal disorder—Epirubicin—testicular cancer	8.37e-05	0.00031	CcSEcCtD
Levofloxacin—Back pain—Methotrexate—testicular cancer	8.36e-05	0.000309	CcSEcCtD
Levofloxacin—Chills—Epirubicin—testicular cancer	8.33e-05	0.000308	CcSEcCtD
Levofloxacin—Pruritus—Etoposide—testicular cancer	8.33e-05	0.000308	CcSEcCtD
Levofloxacin—Arrhythmia—Epirubicin—testicular cancer	8.3e-05	0.000307	CcSEcCtD
Levofloxacin—Visual impairment—Doxorubicin—testicular cancer	8.28e-05	0.000307	CcSEcCtD
Levofloxacin—Alopecia—Epirubicin—testicular cancer	8.21e-05	0.000304	CcSEcCtD
Levofloxacin—Vomiting—Cisplatin—testicular cancer	8.17e-05	0.000302	CcSEcCtD
Levofloxacin—Vision blurred—Methotrexate—testicular cancer	8.14e-05	0.000301	CcSEcCtD
Levofloxacin—Mental disorder—Epirubicin—testicular cancer	8.14e-05	0.000301	CcSEcCtD
Levofloxacin—Erythema multiforme—Doxorubicin—testicular cancer	8.12e-05	0.000301	CcSEcCtD
Levofloxacin—Rash—Cisplatin—testicular cancer	8.1e-05	0.0003	CcSEcCtD
Levofloxacin—Dermatitis—Cisplatin—testicular cancer	8.09e-05	0.0003	CcSEcCtD
Levofloxacin—Erythema—Epirubicin—testicular cancer	8.08e-05	0.000299	CcSEcCtD
Levofloxacin—Malnutrition—Epirubicin—testicular cancer	8.08e-05	0.000299	CcSEcCtD
Levofloxacin—Diarrhoea—Etoposide—testicular cancer	8.05e-05	0.000298	CcSEcCtD
Levofloxacin—Eye disorder—Doxorubicin—testicular cancer	8.03e-05	0.000297	CcSEcCtD
Levofloxacin—Ill-defined disorder—Methotrexate—testicular cancer	8.01e-05	0.000297	CcSEcCtD
Levofloxacin—Tinnitus—Doxorubicin—testicular cancer	8.01e-05	0.000297	CcSEcCtD
Levofloxacin—Anaemia—Methotrexate—testicular cancer	7.98e-05	0.000296	CcSEcCtD
Levofloxacin—Cardiac disorder—Doxorubicin—testicular cancer	7.97e-05	0.000295	CcSEcCtD
Levofloxacin—Flushing—Doxorubicin—testicular cancer	7.97e-05	0.000295	CcSEcCtD
Levofloxacin—Flatulence—Epirubicin—testicular cancer	7.97e-05	0.000295	CcSEcCtD
Levofloxacin—Tension—Epirubicin—testicular cancer	7.93e-05	0.000294	CcSEcCtD
Levofloxacin—Dysgeusia—Epirubicin—testicular cancer	7.92e-05	0.000293	CcSEcCtD
Levofloxacin—Nervousness—Epirubicin—testicular cancer	7.85e-05	0.000291	CcSEcCtD
Levofloxacin—Back pain—Epirubicin—testicular cancer	7.82e-05	0.000289	CcSEcCtD
Levofloxacin—Angiopathy—Doxorubicin—testicular cancer	7.8e-05	0.000289	CcSEcCtD
Levofloxacin—Malaise—Methotrexate—testicular cancer	7.79e-05	0.000288	CcSEcCtD
Levofloxacin—Dizziness—Etoposide—testicular cancer	7.78e-05	0.000288	CcSEcCtD
Levofloxacin—Muscle spasms—Epirubicin—testicular cancer	7.77e-05	0.000288	CcSEcCtD
Levofloxacin—Immune system disorder—Doxorubicin—testicular cancer	7.76e-05	0.000287	CcSEcCtD
Levofloxacin—Vertigo—Methotrexate—testicular cancer	7.76e-05	0.000287	CcSEcCtD
Levofloxacin—Mediastinal disorder—Doxorubicin—testicular cancer	7.74e-05	0.000287	CcSEcCtD
Levofloxacin—Leukopenia—Methotrexate—testicular cancer	7.73e-05	0.000286	CcSEcCtD
Levofloxacin—Chills—Doxorubicin—testicular cancer	7.71e-05	0.000285	CcSEcCtD
Levofloxacin—Arrhythmia—Doxorubicin—testicular cancer	7.68e-05	0.000284	CcSEcCtD
Levofloxacin—Nausea—Cisplatin—testicular cancer	7.63e-05	0.000282	CcSEcCtD
Levofloxacin—Vision blurred—Epirubicin—testicular cancer	7.62e-05	0.000282	CcSEcCtD
Levofloxacin—Alopecia—Doxorubicin—testicular cancer	7.59e-05	0.000281	CcSEcCtD
Levofloxacin—Cough—Methotrexate—testicular cancer	7.54e-05	0.000279	CcSEcCtD
Levofloxacin—Mental disorder—Doxorubicin—testicular cancer	7.53e-05	0.000279	CcSEcCtD
Levofloxacin—Ill-defined disorder—Epirubicin—testicular cancer	7.5e-05	0.000278	CcSEcCtD
Levofloxacin—Vomiting—Etoposide—testicular cancer	7.48e-05	0.000277	CcSEcCtD
Levofloxacin—Erythema—Doxorubicin—testicular cancer	7.48e-05	0.000277	CcSEcCtD
Levofloxacin—Malnutrition—Doxorubicin—testicular cancer	7.48e-05	0.000277	CcSEcCtD
Levofloxacin—Anaemia—Epirubicin—testicular cancer	7.47e-05	0.000277	CcSEcCtD
Levofloxacin—Agitation—Epirubicin—testicular cancer	7.43e-05	0.000275	CcSEcCtD
Levofloxacin—Rash—Etoposide—testicular cancer	7.42e-05	0.000275	CcSEcCtD
Levofloxacin—Dermatitis—Etoposide—testicular cancer	7.41e-05	0.000274	CcSEcCtD
Levofloxacin—Headache—Etoposide—testicular cancer	7.37e-05	0.000273	CcSEcCtD
Levofloxacin—Flatulence—Doxorubicin—testicular cancer	7.37e-05	0.000273	CcSEcCtD
Levofloxacin—Chest pain—Methotrexate—testicular cancer	7.35e-05	0.000272	CcSEcCtD
Levofloxacin—Arthralgia—Methotrexate—testicular cancer	7.35e-05	0.000272	CcSEcCtD
Levofloxacin—Myalgia—Methotrexate—testicular cancer	7.35e-05	0.000272	CcSEcCtD
Levofloxacin—Tension—Doxorubicin—testicular cancer	7.34e-05	0.000272	CcSEcCtD
Levofloxacin—Dysgeusia—Doxorubicin—testicular cancer	7.32e-05	0.000271	CcSEcCtD
Levofloxacin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	7.3e-05	0.00027	CcSEcCtD
Levofloxacin—Malaise—Epirubicin—testicular cancer	7.29e-05	0.00027	CcSEcCtD
Levofloxacin—Discomfort—Methotrexate—testicular cancer	7.27e-05	0.000269	CcSEcCtD
Levofloxacin—Nervousness—Doxorubicin—testicular cancer	7.26e-05	0.000269	CcSEcCtD
Levofloxacin—Vertigo—Epirubicin—testicular cancer	7.26e-05	0.000269	CcSEcCtD
Levofloxacin—Syncope—Epirubicin—testicular cancer	7.25e-05	0.000268	CcSEcCtD
Levofloxacin—Leukopenia—Epirubicin—testicular cancer	7.24e-05	0.000268	CcSEcCtD
Levofloxacin—Back pain—Doxorubicin—testicular cancer	7.24e-05	0.000268	CcSEcCtD
Levofloxacin—Muscle spasms—Doxorubicin—testicular cancer	7.19e-05	0.000266	CcSEcCtD
Levofloxacin—Palpitations—Epirubicin—testicular cancer	7.14e-05	0.000264	CcSEcCtD
Levofloxacin—Confusional state—Methotrexate—testicular cancer	7.11e-05	0.000263	CcSEcCtD
Levofloxacin—Loss of consciousness—Epirubicin—testicular cancer	7.11e-05	0.000263	CcSEcCtD
Levofloxacin—Cough—Epirubicin—testicular cancer	7.05e-05	0.000261	CcSEcCtD
Levofloxacin—Anaphylactic shock—Methotrexate—testicular cancer	7.05e-05	0.000261	CcSEcCtD
Levofloxacin—Vision blurred—Doxorubicin—testicular cancer	7.05e-05	0.000261	CcSEcCtD
Levofloxacin—Infection—Methotrexate—testicular cancer	7e-05	0.000259	CcSEcCtD
Levofloxacin—Nausea—Etoposide—testicular cancer	6.99e-05	0.000259	CcSEcCtD
Levofloxacin—Hypertension—Epirubicin—testicular cancer	6.98e-05	0.000258	CcSEcCtD
Levofloxacin—Ill-defined disorder—Doxorubicin—testicular cancer	6.94e-05	0.000257	CcSEcCtD
Levofloxacin—Nervous system disorder—Methotrexate—testicular cancer	6.91e-05	0.000256	CcSEcCtD
Levofloxacin—Anaemia—Doxorubicin—testicular cancer	6.91e-05	0.000256	CcSEcCtD
Levofloxacin—Thrombocytopenia—Methotrexate—testicular cancer	6.9e-05	0.000256	CcSEcCtD
Levofloxacin—Arthralgia—Epirubicin—testicular cancer	6.88e-05	0.000255	CcSEcCtD
Levofloxacin—Chest pain—Epirubicin—testicular cancer	6.88e-05	0.000255	CcSEcCtD
Levofloxacin—Myalgia—Epirubicin—testicular cancer	6.88e-05	0.000255	CcSEcCtD
Levofloxacin—Agitation—Doxorubicin—testicular cancer	6.87e-05	0.000254	CcSEcCtD
Levofloxacin—Anxiety—Epirubicin—testicular cancer	6.86e-05	0.000254	CcSEcCtD
Levofloxacin—Skin disorder—Methotrexate—testicular cancer	6.85e-05	0.000253	CcSEcCtD
Levofloxacin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	6.83e-05	0.000253	CcSEcCtD
Levofloxacin—Hyperhidrosis—Methotrexate—testicular cancer	6.82e-05	0.000252	CcSEcCtD
Levofloxacin—Discomfort—Epirubicin—testicular cancer	6.8e-05	0.000252	CcSEcCtD
Levofloxacin—Malaise—Doxorubicin—testicular cancer	6.75e-05	0.00025	CcSEcCtD
Levofloxacin—Dry mouth—Epirubicin—testicular cancer	6.73e-05	0.000249	CcSEcCtD
Levofloxacin—Vertigo—Doxorubicin—testicular cancer	6.72e-05	0.000249	CcSEcCtD
Levofloxacin—Anorexia—Methotrexate—testicular cancer	6.72e-05	0.000249	CcSEcCtD
Levofloxacin—Syncope—Doxorubicin—testicular cancer	6.71e-05	0.000248	CcSEcCtD
Levofloxacin—Leukopenia—Doxorubicin—testicular cancer	6.7e-05	0.000248	CcSEcCtD
Levofloxacin—Confusional state—Epirubicin—testicular cancer	6.65e-05	0.000246	CcSEcCtD
Levofloxacin—Palpitations—Doxorubicin—testicular cancer	6.61e-05	0.000245	CcSEcCtD
Levofloxacin—Anaphylactic shock—Epirubicin—testicular cancer	6.6e-05	0.000244	CcSEcCtD
Levofloxacin—Oedema—Epirubicin—testicular cancer	6.6e-05	0.000244	CcSEcCtD
Levofloxacin—Hypotension—Methotrexate—testicular cancer	6.59e-05	0.000244	CcSEcCtD
Levofloxacin—Loss of consciousness—Doxorubicin—testicular cancer	6.57e-05	0.000243	CcSEcCtD
Levofloxacin—Infection—Epirubicin—testicular cancer	6.55e-05	0.000243	CcSEcCtD
Levofloxacin—Cough—Doxorubicin—testicular cancer	6.53e-05	0.000242	CcSEcCtD
Levofloxacin—Shock—Epirubicin—testicular cancer	6.49e-05	0.00024	CcSEcCtD
Levofloxacin—Nervous system disorder—Epirubicin—testicular cancer	6.47e-05	0.000239	CcSEcCtD
Levofloxacin—Thrombocytopenia—Epirubicin—testicular cancer	6.46e-05	0.000239	CcSEcCtD
Levofloxacin—Hypertension—Doxorubicin—testicular cancer	6.46e-05	0.000239	CcSEcCtD
Levofloxacin—Tachycardia—Epirubicin—testicular cancer	6.44e-05	0.000238	CcSEcCtD
Levofloxacin—Musculoskeletal discomfort—Methotrexate—testicular cancer	6.42e-05	0.000238	CcSEcCtD
Levofloxacin—Skin disorder—Epirubicin—testicular cancer	6.41e-05	0.000237	CcSEcCtD
Levofloxacin—Hyperhidrosis—Epirubicin—testicular cancer	6.38e-05	0.000236	CcSEcCtD
Levofloxacin—Insomnia—Methotrexate—testicular cancer	6.38e-05	0.000236	CcSEcCtD
Levofloxacin—Chest pain—Doxorubicin—testicular cancer	6.37e-05	0.000236	CcSEcCtD
Levofloxacin—Myalgia—Doxorubicin—testicular cancer	6.37e-05	0.000236	CcSEcCtD
Levofloxacin—Arthralgia—Doxorubicin—testicular cancer	6.37e-05	0.000236	CcSEcCtD
Levofloxacin—Anxiety—Doxorubicin—testicular cancer	6.35e-05	0.000235	CcSEcCtD
Levofloxacin—Paraesthesia—Methotrexate—testicular cancer	6.33e-05	0.000234	CcSEcCtD
Levofloxacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	6.32e-05	0.000234	CcSEcCtD
Levofloxacin—Discomfort—Doxorubicin—testicular cancer	6.29e-05	0.000233	CcSEcCtD
Levofloxacin—Anorexia—Epirubicin—testicular cancer	6.29e-05	0.000233	CcSEcCtD
Levofloxacin—Dyspnoea—Methotrexate—testicular cancer	6.29e-05	0.000233	CcSEcCtD
Levofloxacin—Somnolence—Methotrexate—testicular cancer	6.27e-05	0.000232	CcSEcCtD
Levofloxacin—Dry mouth—Doxorubicin—testicular cancer	6.23e-05	0.000231	CcSEcCtD
Levofloxacin—Dyspepsia—Methotrexate—testicular cancer	6.21e-05	0.00023	CcSEcCtD
Levofloxacin—Hypotension—Epirubicin—testicular cancer	6.17e-05	0.000228	CcSEcCtD
Levofloxacin—Confusional state—Doxorubicin—testicular cancer	6.16e-05	0.000228	CcSEcCtD
Levofloxacin—Decreased appetite—Methotrexate—testicular cancer	6.13e-05	0.000227	CcSEcCtD
Levofloxacin—Oedema—Doxorubicin—testicular cancer	6.1e-05	0.000226	CcSEcCtD
Levofloxacin—Anaphylactic shock—Doxorubicin—testicular cancer	6.1e-05	0.000226	CcSEcCtD
Levofloxacin—Gastrointestinal disorder—Methotrexate—testicular cancer	6.09e-05	0.000225	CcSEcCtD
Levofloxacin—Fatigue—Methotrexate—testicular cancer	6.08e-05	0.000225	CcSEcCtD
Levofloxacin—Infection—Doxorubicin—testicular cancer	6.06e-05	0.000224	CcSEcCtD
Levofloxacin—Pain—Methotrexate—testicular cancer	6.03e-05	0.000223	CcSEcCtD
Levofloxacin—Musculoskeletal discomfort—Epirubicin—testicular cancer	6.01e-05	0.000223	CcSEcCtD
Levofloxacin—Shock—Doxorubicin—testicular cancer	6.01e-05	0.000222	CcSEcCtD
Levofloxacin—Nervous system disorder—Doxorubicin—testicular cancer	5.99e-05	0.000222	CcSEcCtD
Levofloxacin—Thrombocytopenia—Doxorubicin—testicular cancer	5.98e-05	0.000221	CcSEcCtD
Levofloxacin—Insomnia—Epirubicin—testicular cancer	5.97e-05	0.000221	CcSEcCtD
Levofloxacin—Tachycardia—Doxorubicin—testicular cancer	5.96e-05	0.000221	CcSEcCtD
Levofloxacin—Skin disorder—Doxorubicin—testicular cancer	5.93e-05	0.000219	CcSEcCtD
Levofloxacin—Paraesthesia—Epirubicin—testicular cancer	5.92e-05	0.000219	CcSEcCtD
Levofloxacin—Hyperhidrosis—Doxorubicin—testicular cancer	5.9e-05	0.000218	CcSEcCtD
Levofloxacin—Dyspnoea—Epirubicin—testicular cancer	5.88e-05	0.000218	CcSEcCtD
Levofloxacin—Somnolence—Epirubicin—testicular cancer	5.87e-05	0.000217	CcSEcCtD
Levofloxacin—Anorexia—Doxorubicin—testicular cancer	5.82e-05	0.000215	CcSEcCtD
Levofloxacin—Feeling abnormal—Methotrexate—testicular cancer	5.81e-05	0.000215	CcSEcCtD
Levofloxacin—Dyspepsia—Epirubicin—testicular cancer	5.81e-05	0.000215	CcSEcCtD
Levofloxacin—Gastrointestinal pain—Methotrexate—testicular cancer	5.76e-05	0.000213	CcSEcCtD
Levofloxacin—Decreased appetite—Epirubicin—testicular cancer	5.74e-05	0.000212	CcSEcCtD
Levofloxacin—Hypotension—Doxorubicin—testicular cancer	5.7e-05	0.000211	CcSEcCtD
Levofloxacin—Gastrointestinal disorder—Epirubicin—testicular cancer	5.7e-05	0.000211	CcSEcCtD
Levofloxacin—Fatigue—Epirubicin—testicular cancer	5.69e-05	0.000211	CcSEcCtD
Levofloxacin—Constipation—Epirubicin—testicular cancer	5.64e-05	0.000209	CcSEcCtD
Levofloxacin—Pain—Epirubicin—testicular cancer	5.64e-05	0.000209	CcSEcCtD
Levofloxacin—Urticaria—Methotrexate—testicular cancer	5.6e-05	0.000207	CcSEcCtD
Levofloxacin—Body temperature increased—Methotrexate—testicular cancer	5.57e-05	0.000206	CcSEcCtD
Levofloxacin—Abdominal pain—Methotrexate—testicular cancer	5.57e-05	0.000206	CcSEcCtD
Levofloxacin—Musculoskeletal discomfort—Doxorubicin—testicular cancer	5.56e-05	0.000206	CcSEcCtD
Levofloxacin—Insomnia—Doxorubicin—testicular cancer	5.52e-05	0.000204	CcSEcCtD
Levofloxacin—Paraesthesia—Doxorubicin—testicular cancer	5.48e-05	0.000203	CcSEcCtD
Levofloxacin—Dyspnoea—Doxorubicin—testicular cancer	5.44e-05	0.000201	CcSEcCtD
Levofloxacin—Feeling abnormal—Epirubicin—testicular cancer	5.44e-05	0.000201	CcSEcCtD
Levofloxacin—Somnolence—Doxorubicin—testicular cancer	5.43e-05	0.000201	CcSEcCtD
Levofloxacin—Gastrointestinal pain—Epirubicin—testicular cancer	5.4e-05	0.0002	CcSEcCtD
Levofloxacin—Dyspepsia—Doxorubicin—testicular cancer	5.37e-05	0.000199	CcSEcCtD
Levofloxacin—Decreased appetite—Doxorubicin—testicular cancer	5.31e-05	0.000196	CcSEcCtD
Levofloxacin—Gastrointestinal disorder—Doxorubicin—testicular cancer	5.27e-05	0.000195	CcSEcCtD
Levofloxacin—Fatigue—Doxorubicin—testicular cancer	5.26e-05	0.000195	CcSEcCtD
Levofloxacin—Urticaria—Epirubicin—testicular cancer	5.24e-05	0.000194	CcSEcCtD
Levofloxacin—Pain—Doxorubicin—testicular cancer	5.22e-05	0.000193	CcSEcCtD
Levofloxacin—Constipation—Doxorubicin—testicular cancer	5.22e-05	0.000193	CcSEcCtD
Levofloxacin—Abdominal pain—Epirubicin—testicular cancer	5.22e-05	0.000193	CcSEcCtD
Levofloxacin—Body temperature increased—Epirubicin—testicular cancer	5.22e-05	0.000193	CcSEcCtD
Levofloxacin—Hypersensitivity—Methotrexate—testicular cancer	5.19e-05	0.000192	CcSEcCtD
Levofloxacin—Asthenia—Methotrexate—testicular cancer	5.06e-05	0.000187	CcSEcCtD
Levofloxacin—Feeling abnormal—Doxorubicin—testicular cancer	5.03e-05	0.000186	CcSEcCtD
Levofloxacin—Gastrointestinal pain—Doxorubicin—testicular cancer	4.99e-05	0.000185	CcSEcCtD
Levofloxacin—Pruritus—Methotrexate—testicular cancer	4.99e-05	0.000185	CcSEcCtD
Levofloxacin—Hypersensitivity—Epirubicin—testicular cancer	4.86e-05	0.00018	CcSEcCtD
Levofloxacin—Urticaria—Doxorubicin—testicular cancer	4.85e-05	0.00018	CcSEcCtD
Levofloxacin—Abdominal pain—Doxorubicin—testicular cancer	4.83e-05	0.000179	CcSEcCtD
Levofloxacin—Body temperature increased—Doxorubicin—testicular cancer	4.83e-05	0.000179	CcSEcCtD
Levofloxacin—Diarrhoea—Methotrexate—testicular cancer	4.82e-05	0.000179	CcSEcCtD
Levofloxacin—Asthenia—Epirubicin—testicular cancer	4.73e-05	0.000175	CcSEcCtD
Levofloxacin—Pruritus—Epirubicin—testicular cancer	4.67e-05	0.000173	CcSEcCtD
Levofloxacin—Dizziness—Methotrexate—testicular cancer	4.66e-05	0.000173	CcSEcCtD
Levofloxacin—Diarrhoea—Epirubicin—testicular cancer	4.51e-05	0.000167	CcSEcCtD
Levofloxacin—Hypersensitivity—Doxorubicin—testicular cancer	4.5e-05	0.000166	CcSEcCtD
Levofloxacin—Vomiting—Methotrexate—testicular cancer	4.48e-05	0.000166	CcSEcCtD
Levofloxacin—Rash—Methotrexate—testicular cancer	4.45e-05	0.000165	CcSEcCtD
Levofloxacin—Dermatitis—Methotrexate—testicular cancer	4.44e-05	0.000164	CcSEcCtD
Levofloxacin—Headache—Methotrexate—testicular cancer	4.42e-05	0.000163	CcSEcCtD
Levofloxacin—Asthenia—Doxorubicin—testicular cancer	4.38e-05	0.000162	CcSEcCtD
Levofloxacin—Dizziness—Epirubicin—testicular cancer	4.36e-05	0.000161	CcSEcCtD
Levofloxacin—Pruritus—Doxorubicin—testicular cancer	4.32e-05	0.00016	CcSEcCtD
Levofloxacin—Vomiting—Epirubicin—testicular cancer	4.19e-05	0.000155	CcSEcCtD
Levofloxacin—Nausea—Methotrexate—testicular cancer	4.19e-05	0.000155	CcSEcCtD
Levofloxacin—Diarrhoea—Doxorubicin—testicular cancer	4.18e-05	0.000155	CcSEcCtD
Levofloxacin—Rash—Epirubicin—testicular cancer	4.16e-05	0.000154	CcSEcCtD
Levofloxacin—Dermatitis—Epirubicin—testicular cancer	4.16e-05	0.000154	CcSEcCtD
Levofloxacin—Headache—Epirubicin—testicular cancer	4.13e-05	0.000153	CcSEcCtD
Levofloxacin—Dizziness—Doxorubicin—testicular cancer	4.04e-05	0.000149	CcSEcCtD
Levofloxacin—Nausea—Epirubicin—testicular cancer	3.92e-05	0.000145	CcSEcCtD
Levofloxacin—Vomiting—Doxorubicin—testicular cancer	3.88e-05	0.000144	CcSEcCtD
Levofloxacin—Rash—Doxorubicin—testicular cancer	3.85e-05	0.000142	CcSEcCtD
Levofloxacin—Dermatitis—Doxorubicin—testicular cancer	3.85e-05	0.000142	CcSEcCtD
Levofloxacin—Headache—Doxorubicin—testicular cancer	3.82e-05	0.000142	CcSEcCtD
Levofloxacin—Nausea—Doxorubicin—testicular cancer	3.63e-05	0.000134	CcSEcCtD
